Cargando…

Cardiovascular and Renal Benefits of SGLT2 Inhibitors: A Narrative Review

CONTEXT: Most recently developed anti-hyperglycemic drugs have offered cardiovascular and renal benefits. In this narrative review, we discuss the cardiovascular and renal benefits of novel antidiabetic drugs, sodium glucose cotransporter type 2 (SGLT2) inhibitors, in type 2 diabetes. EVIDENCE ACQUI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rabizadeh, Soghra, Nakhjavani, Manouchehr, Esteghamati, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628616/ https://www.ncbi.nlm.nih.gov/pubmed/31372172 http://dx.doi.org/10.5812/ijem.84353

Ejemplares similares

Response to the letter to the editor concerning the manuscript, “Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates”
por: Rabizadeh, Soghra, et al.
Publicado: (2022)

Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates?
por: Rabizadeh, Soghra, et al.
Publicado: (2021)

Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes
por: Samimi, Sahar, et al.
Publicado: (2022)

Effects of Pentoxifylline on Serum Markers of Diabetic Nephropathy in Type 2 Diabetes
por: Moosaie, Fatemeh, et al.
Publicado: (2022)

Decreasing trend of blood lipid profile in type 2 diabetes: Not a promising change in HDL-C, a serial cross-sectional study
por: Yadegar, Amirhossein, et al.
Publicado: (2023)

Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: A cross‐sectional survey of a regional cohort
por: Yadegar, Amirhossein, et al.
Publicado: (2023)

Lipid profile, ox‐LDL, and LCAT activity in patients with endometrial carcinoma and type 2 diabetes: The effect of concurrent disease based on a case–control study
por: Qahremani, Reihane, et al.
Publicado: (2023)

Waist-To-Height Ratio Is a More Accurate Tool for Predicting Hypertension Than Waist-To-Hip Circumference and BMI in Patients With Type 2 Diabetes: A Prospective Study
por: Moosaie, Fatemeh, et al.
Publicado: (2021)

Pulse pressure and diabetes treatments: Blood pressure and pulse pressure difference among glucose lowering modality groups in type 2 diabetes
por: Alemi, Hamid, et al.
Publicado: (2018)

Improvement in Redox Homeostasis after Cytoreductive Surgery in Colorectal Adenocarcinoma
por: Salehi, Salome Sadat, et al.
Publicado: (2021)

Comparison of insulin resistance indices in predicting albuminuria among patients with type 2 diabetes
por: Nabipoorashrafi, Seyed Ali, et al.
Publicado: (2023)

The lack of association between different LDL‐C levels and oxidized LDL in patients with type 2 diabetes
por: Rabizadeh, Soghra, et al.
Publicado: (2023)

Vitamin C supplementation lowers advanced glycation end products (AGEs) and malondialdehyde (MDA) in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled clinical trial
por: Rabizadeh, Soghra, et al.
Publicado: (2023)

Bilateral inferior petrosal sinus sampling: validity, diagnostic accuracy in lateralization of pituitary microadenoma, and treatment in eleven patients with Cushing’s syndrome – a single-center retrospective cohort study
por: Ardakani, Mohammadali Tavakoli, et al.
Publicado: (2023)

Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
por: Ebrahimi, Menooa, et al.
Publicado: (2023)

Pathophysiological basis of the cardiological benefits of SGLT-2 inhibitors: a narrative review
por: Panico, Cristina, et al.
Publicado: (2023)

Therapeutic effects of resveratrol and Omega-3 in mice atherosclerosis: focus on histopathological changes
por: Mosavi, Shamsi Sadat, et al.
Publicado: (2023)

Fibrosis score 4 index has an independent relationship with coronary artery diseases in patients with metabolic-associated fatty liver disease
por: Namakchian, Maryam, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study
por: Deravi, Niloofar, et al.
Publicado: (2023)

Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome
por: Esteghamati, Alireza, et al.
Publicado: (2006)

The association between advanced glycation end products (AGEs) and ABC (hemoglobin A1C, blood pressure, and low-density lipoprotein cholesterol) control parameters among patients with type 2 diabetes mellitus
por: Rezaei, Mohaddeseh, et al.
Publicado: (2022)

Serum lipoprotein(a) and reclassification of coronary heart disease risk; application of prediction in a cross-sectional analysis of an ongoing Iranian cohort
por: Ghavami, Mojgan, et al.
Publicado: (2023)

Pioglitazone and metformin are equally effective in reduction of chemerin in patients with type 2 diabetes
por: Esteghamati, Alireza, et al.
Publicado: (2013)

Appearance of leptin–HSP70 correlation, in type 2 diabetes()
por: Nakhjavani, Manouchehr, et al.
Publicado: (2013)

Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
por: Margonato, Davide, et al.
Publicado: (2020)

Renal and Cardiovascular Metabolic Impact Caused by Ketogenesis of the SGLT2 Inhibitors
por: Vargas-Delgado, Ariana P., et al.
Publicado: (2023)

Response: Association of Vaspin with Metabolic Syndrome: The Pivotal Role of Insulin Resistance (Diabetes Metab J 2014;38:143-9)
por: Esteghamati, Alireza, et al.
Publicado: (2014)

Association of Vaspin with Metabolic Syndrome: The Pivotal Role of Insulin Resistance
por: Esteghamati, Alireza, et al.
Publicado: (2014)

SGLT-2 Inhibitors and Cardiovascular Protection: Lessons and Gaps in Understanding the Current Outcome Trials and Possible Benefits of Combining SGLT-2 Inhibitors With GLP-1 Agonists
por: Abdelgadir, Elamin, et al.
Publicado: (2018)

Combination of Angiotensin Converting Enzyme Insertion/Deletion (I/D) (rs4646994) and VEGF Polymorphism (+405G/C; rs2010963) Synergistically Associated With the Development, of Albuminuria in Iranian Patients With Type 2 Diabetes
por: Fathi, Mohammad, et al.
Publicado: (2015)

Benefits of SGLT2 inhibitors in arrhythmias
por: Gao, Jinghan, et al.
Publicado: (2022)

SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
por: Thomas, Merlin C, et al.
Publicado: (2023)

Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status
por: Nakhjavani, Manouchehr, et al.
Publicado: (2014)

Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same? A Narrative Review of Cardiovascular Outcome Trials
por: Williams, David M., et al.
Publicado: (2020)

Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial
por: Ghoreishy, Seyed Mojtaba, et al.
Publicado: (2022)

Albuminuria and its correlates in an Iranian type 2 diabetic population
por: Nakhjavani, Manouchehr, et al.
Publicado: (2008)

SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
por: Ali, Amar, et al.
Publicado: (2019)

SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative Review
por: Lu, Henri, et al.
Publicado: (2021)

Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
por: Evans, Marc, et al.
Publicado: (2019)

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review
por: Lopaschuk, Gary D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jp897mo507p85mv40920r7uq0g